商品分类

浏览历史

B20075	宝藿苷I
源叶	分析标准品,HPLC≥98%

英文名：
Baohuoside I

别名：
淫羊藿次苷II; 宝藿苷 I; 宝藿苷Ⅰ; 淫羊藿次苷II;

CAS号：
113558-15-9

分子式：
C₂₇H₃₀O₁₀

分子量：
514.52

MDL：
MFCD15071140

核磁/质谱：

品牌	货号	产品规格	价格(RMB)	库存（上海）	北京	武汉	南京	数量	计量单位	加入购物车...
源叶	B20075-20mg	分析标准品,HPLC≥98%	￥300.00元	>10	2	1	2		EA	加入购物车
源叶	B20075-200mg	分析标准品,HPLC≥98%	￥1200.00元	>10	2	-	3		EA	加入购物车

大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》，到货后将短信提示。
提交

产品介绍

参考文献(40篇)

质检证书(COA)

摩尔浓度计算器

相关产品

熔点： 202-203°C

沸点： 759.4°C at 760mmHg

比旋光度： (c, 0.09 in MeOH)-121

外观：黄色针状结晶

溶解性： DMSO : ≥ 32 mg/mL (62.19 mM)

储存条件： 2-8℃

注意：部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

40. [2.1] Jun-Tao Sun et al."Exploring the protective effect and mechanism of icariside II on the bladder in a rat model of radiation cystitis based on transcriptome sequencing."INTERNATIONAL JOURNAL OF RADIATION BIOLOGY.

39. [4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15:

38. [IF=6.1] Xiuchun Li et al."Icariside II alleviates lipopolysaccharide-induced acute lung injury by inhibiting lung epithelial inflammatory and immune responses mediated by neutrophil extracellular traps."LIFE SCIENCES".2024 Jun;346:122648

37. [IF=6] Dong Xie et al."Pharmacodynamic material basis and mechanism of Tenghuang Jiangu Wan on osteoarthritis using UPLC-Q-TOF-MS integrated with target network pharmacology."Arabian Journal of Chemistry".2024 Apr;17:105711

36. [IF=1.6] Liu Huimin et al."Identification and Characterization of the Chemical Constituents of Qianlie Shule Capsules by UPLC-Q-Orbitrap-MS/MS."JOURNAL OF AOAC INTERNATIONAL".2024 Feb;:

35. [IF=8.4] Ting An et al."De novo biosynthesis of anticarcinogenic icariin in engineered yeast."METABOLIC ENGINEERING.2023 Nov;80:207

34. [IF=5.4] Yi-min Liu et al."Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of Epimedium against liver cancer through a comprehensive investigation."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116765

33. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176:

32. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646

31. [6.832] Li Zhang et al."Erxian herbal pair enhances bone formation in infected bone nonunion models and attenuates lipopolysaccharide-induced osteoblastinhibition by regulating miRNA-34a-5p."Bioengineered.2022;13(6):14339-14356

30. [6.208] Yu Yao et al."A Novel 3-O-rhamnoside: 2″-O-xylosyltransferase Responsible for Terminal Modification of Prenylflavonol Glycosides in Epimedium pubescens Maxim.."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(24):16050

29. [IF=5.895] Fang Liu et al."Co-Immobilizing Two Glycosidases Based on Cross-Linked Enzyme Aggregates to Enhance Enzymatic Properties for Achieving High Titer Icaritin Biosynthesis."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2022;XXXX(XXX):XXX-XXX

28. [IF=5.988] Li Pin et al."Epimedium koreanum Nakai–Induced Liver Injury—A Mechanistic Study Using Untargeted Metabolomics."Frontiers in Pharmacology.2022 Jul;0:2288

27. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21

26. [IF=2.886] Yangyang Guo et al."Baohuoside I via mTOR Apoptotic Signaling to Inhibit Glioma Cell Growth."Cancer Manag Res. 2020; 12: 11435–11444

25. [IF=2.886] Fubiao Ni et al."Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling."Cancer Manag Res. 2019; 11: 10609–10621

24. [IF=3.645] Hongmin Zhang et al."Simultaneous determination of five isoflavones in rat plasma by LC-MS/MS: Comparative pharmacokinetic characteristics of Puerariae lobatae radix in normal and type 2 diabetic rats."J Sep Sci. 2019 Aug;42(16):2592-2601

23. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80

22. [IF=4.36] Kun Shi et al."Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway."J Ethnopharmacol. 2022 Feb;284:114766

21. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137

20. [IF=3.263] Jing Yang et al."Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells."Eur J Pharmacol. 2019 Mar;846:12

19. [IF=6.529] Congyan Liu et al."Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats."Biomed Pharmacother. 2017 Oct;94:1048

18. Liu, Congyan, et al. "Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats." Biomedicine & Pharmacotherapy 94 (2017): 1048-1056.https://doi.org/10.1016/j.biopha.2017.07.163

17. Yang, Jing, et al. "Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells." European journal of pharmacology 846 (2019): 12-22.https://doi.org/10.1016/j.ejphar.2018.12.026

16. 许婷,黄萌萌,李瑞云,杨茹,刘丽芳,陈彦.多基原淫羊藿不同部位质量评价研究[J].中草药,2020,51(01):190-196.

15. 刘聪燕,李瑞云,马程遥,刘玉萍,瞿鼎,李晓琦,陈彦.壳聚糖交联介孔二氧化硅固定化β-葡萄糖苷酶生物转化淫羊藿苷研究[J].中草药,2021,52(03):685-691.

14. 彭静, 马益华, 陈彦,等. 固定化蜗牛酶同时生物转化淫羊藿中4种黄酮苷[J]. 中成药, 2016, 38(9):1984-1990.

13. 高霞, 陈彦, 王莹,等. 糊精湿法制粒对淫羊藿总黄酮酶解的影响[J]. 中成药, 2014, 36(007):1392-1397.

12. 高霞, 刘璇, 陈彦,等. 淫羊藿总黄酮的生物转化过程分析[J]. 中国中药杂志, 2013, 38(23):4079.

11. 刘聪燕, 高霞, 陈彦,等. 淫羊藿总黄酮在骨质疏松大鼠体内的药动学行为[J]. 中成药, 2017, 39(008):1595-1600.

10. 刘聪燕, 高霞, 黄萌萌,等. 淫羊藿总黄酮仿生酶解肠溶胶囊的制备及评价[J]. 中草药, 2016(20).

9. 张燕. 大孔吸附树脂分离纯化淫羊藿EF5黄酮[J]. 北方药学, 2015, 000(011):11-13.

8. 刘聪燕高霞陈彦等. 仿生酶解肠溶胶囊提高淫羊藿总黄酮口服生物利用度的可行性研究[J]. 中国医药工业杂志 2016(9期):1158-1164.

7. 王莹高霞陈彦等. 卡波姆对淫羊藿总黄酮酶解效果的影响[J]. 中国实验方剂学杂志 2014 20(009):1-5.

6. 杨茹刘聪燕许婷等. 5种大孔吸附树脂对淫羊藿总黄酮的吸附特性考察[J]. 中国实验方剂学杂志 2020 v.26(06):121-128.

5. 顾慧敏, 孙娥, 李杰,等. 炮制辅料羊脂油对宝藿苷Ⅰ-胆酸盐自组装胶束形成与吸收的影响[J]. 中国中药杂志, 2019, v.44(23):133-140.

4. 刘玉萍, 丁学芳, 黄萌萌,等. 淫羊藿苷在不同骨质疏松大鼠模型中肠道吸收代谢研究[J]. 中国中药杂志, 2016(13):2532-2537.

3. 高霞, 陈彦, 王莹,等. 淫羊藿苷仿生酶解过程的多因素考察[J]. 药学学报, 2013(11):1716-1721.

2. 李瑞云刘聪燕许婷等. 交联纳米SiO_2固定化蜗牛酶的制备表征及转化淫羊藿苷研究[J]. 中草药 2019 v.50;No.655(20):57-63.

1. 杨轶舜张彤丁越等. 3种淫羊藿苷次生产物的制备及HPLC测定[J]. 中成药 2020 042(003):779-782.